Call runs ahead of the accounts: the business management describes is already operating beyond the period it is reportin
The model's full reasoning — Q3 2021 call → NOWe need to determine if there is a clear gap between the trailing period being reported and the level at which the business is already operating right now, as described by management. The transcript is for Q3 2021 earnings call. Management discusses results for Q3 2021, but also talks about current operations and future expectations. Key points from the call: - Mark Ordan: "our patient volumes, revenue and adjusted EBITDA were all ahead of the same period in 2019, which suggests that at this time, our business has more than recovered from the significant negative impact to the COVID-19 pandemic that we experienced in 2020 and earlier this year." This indicates that the current business is already above pre-pandemic levels, but the reported period is Q3 2021, which is compared to 2019. So the reported period already reflects that recovery? Actually, they say "our patient volumes, revenue and adjusted EBITDA were all ahead of the same period in 2019" for the quarter. So the reported quarter itself is already ahead of 2019. So the print already reflects that. But then they say "we now expect that our 2021 adjusted EBITDA will exceed our prior internal expectation of being above $240 million, and we now expect 2021 adjusted EBITDA of at least $250 million." That's guidance for the full year, not necessarily a gap between current operations and the reported quarter. - They also discuss growth efforts: "we estimate that we have added approximately three percentage points to our adjusted EBITDA growth versus 2020, over and above the pure same-store growth that our affiliated practices have experienced." That's about growth initiatives. - They discuss Brave Care investment: "we recently announced our investment in Brave Care" and talk about opening more than 100 pediatric clinics across our footprint within a few years. That's future plans, not yet realized. - They discuss RCM transition: "our overall spend in Q3 was down about $4 million sequentially. This primarily reflects sequential reductions in certain operating and legal expenses as well as RCM savings related to our agreement with R1, which should increase further in Q4." So the RCM savings are already partially in Q3, but more to come in Q4. - They discuss the PSA arrangement: "we also completed the support services related to the PSA arrangement attached to last year's sale of our anesthesia organization.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
BFI · Q3 2021 → YESThe question is whether there's a clear gap between the trailing period being reported (Q3 2021) and the current operating level, as told by management. YES The transcript shows management treating the Q3 results as trailing behind the combined company's current scale. Ian Baines opens by noting the November 3 acquisition closed just days before the call, immediately framing the business as now operating under the combined structure with 61 new locations. Julio Ramirez and Mike Rabinovitch repeatedly reference 2021 developments that occurred after September 30—10 new restaurant openings including one in October, 15 additional Ghost Kitchens, 32 signed leases, and the acquisition itself—as already-real activity driving the current state.
ADSE · Q4 2021 → YESThe question is: Is there a clear gap between the trailing period being reported and the level at which the business is already operating right now, such that management describes a company that has a...YES The transcript shows a clear gap. Management repeatedly frames the company as already operating at a higher level than the 2021 print: a €60 million+ order backlog (explicitly “year-to-date” and “just completed Q1”), U.S. business launched in late 2021 with “initial success … world orders received,” a signed ChargePost contract for 50 units with plans for >10,000 more, U.S. manufacturing plant search already underway with opening expected this year, service contracts expected to start in 2022, and new hires completed.
BFIN · Q1 2022 → YESThe question is whether there's a clear gap between the trailing period being reported (Q1 2022) and the current operating level, as described by management. YES The transcript shows management explicitly updating on April activity as already real and substantial, with loan growth hitting $45 million in April alone (pushing the portfolio over $1.1 billion), Equipment Finance originating more in April than the entire Q1, and overall originations at $148 million in April.